These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7589023)

  • 1. Haemodynamic evaluation of two regimens of molsidomine in patients with chronic congestive heart failure.
    Lehmann G; Reiniger G; Beyerle A; Zeitler H; Rudolph W
    Eur J Clin Pharmacol; 1995; 48(2):109-14. PubMed ID: 7589023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
    Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the haemodynamic effects of oral molsidomine and isosorbide dinitrate in man.
    Vogt A; Kreuzer H
    Eur J Clin Pharmacol; 1982; 23(1):11-4. PubMed ID: 6897039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of molsidomine on hemodynamics in patients with dilated cardiomyopathy].
    Hackl W; Frohner K; Podczek A; Unger G; Steinbach K
    Wien Klin Wochenschr; 1986 Sep; 98(17):581-4. PubMed ID: 3765647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses.
    Walter M; Liebens I; Goethals H; Renard M; Dresse A; Bernard R
    Br J Clin Pharmacol; 1988 Mar; 25(3):323-9. PubMed ID: 3282531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.
    Kassis E; Amtorp O; Waldorff S; Fritz-Hansen P
    Br Heart J; 1987 Nov; 58(5):505-11. PubMed ID: 3314956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of corvaton in the long-term ambulatory treatment of heart failure in patients with rheumatic heart lesions].
    Koshlia VI
    Ter Arkh; 1986; 58(11):51-5. PubMed ID: 3824191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic changes produced by molsidomine in patients with congestive myocardiopathy.
    Otero F; Fernández Berges DJ; Milei J; Agejas R; Vázquez A; Pautasso E
    Acta Cardiol; 1984; 39(5):353-63. PubMed ID: 6334953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
    Acar J; Kulas A; Escudier B
    Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment.
    Lampert E; Tuo N; Frans A; Lonsdorfer J
    Pathol Biol (Paris); 1991 Jan; 39(1):29-33. PubMed ID: 2011406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure.
    Tebbe U; Wurst W; Neuhaus KL
    Eur J Clin Pharmacol; 1988; 35(3):305-8. PubMed ID: 3181283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.